Metabolic approach could have potential in reducing lupus flares

The diabetes drug metformin could hold potential as a treatment for reducing the incidence of flares in people with lupus, a small study suggests. The trial from Shanghai included patients with mild disease on standard immunosuppressive treatment who were randomised to receive metformin (n=67; 0.5g up to three times a day) or placebo (n=73). At ...

Already a member?

Login to keep reading.

© 2021 the limbic